Choice of Seizure Medication for Post-Stroke Epilepsy May Influence Survival
By Megan Brooks (Reuters Health)
|
on January 13, 2022
|
0 Comment
The researchers caution that they lacked information about all factors influencing ASM drug selection and some confounding likely occurred. Also, the findings are based only on post-stroke epilepsy patients using a single ASM and do not pertain to patients requiring drug changes for seizure control.
The study was funded by grants from the Swedish state under the ALF agreement, and grants from the Swedish Society of Medicine, the Swedish Society of Medical Research, the Linnea and Josef Carlsson Foundation, the Goteborg Medical Society, and the Magnus Bergvall Foundation. Dr. Larsson has no relevant disclosures.
Pages: 1 2 | Single Page
Related
-
ACEP Clinical Policy on Thrombolytics for Management of Acute Ischemic Stroke
July 3, 2025 - 0 Comment -
Evidence Mounts Backing Rescue Ketamine for Prehospital Status Epilepticus
April 30, 2025 - 0 Comment -
ACEP Clinical Policy on Seizures
April 23, 2025 - 0 Comment
No Responses to “Choice of Seizure Medication for Post-Stroke Epilepsy May Influence Survival”